专题：Biological Agents for Bioterrorism

This cluster of papers focuses on the study of biological agents with potential for bioterrorism, including anthrax, tularemia, Bacillus cereus, and Francisella tularensis. The research covers various aspects such as pathogenesis, genomic analysis, inhalational anthrax cases, toxins, and public health assessments related to these biological agents.
最新文献
“ Small-molecule inhibition of the Hbsu/BaHU-DNA binding interface to downregulate the pXO1 atxA regulon.”

article Full Text OpenAlex

Cybersecurity preparedness and resilience in health care: a narrative review

article Full Text OpenAlex

Field evaluation of a rapid antigen test for mpox in the Democratic Republic of the Congo and Uganda: a multicentre, prospective, diagnostic accuracy study

article Full Text OpenAlex

Assessing mpox epidemic readiness status in ECOWAS region: strengths, gaps, and recommendations for an improved response.

article Full Text OpenAlex

Lightweight multiscale early warning system for influenza A spillovers

article Full Text OpenAlex

Epidemiology of anthrax in Andhra Pradesh

article Full Text OpenAlex

Novel strategies for post-exposure rabies prophylaxis: the role of immunomodulatory and targeted molecular technologies in personalized medicine

article Full Text OpenAlex

Paratyphoid fever and relapsing fever in 1812 Napoleon's devastated army

article Full Text OpenAlex

Global Transmission, Prevention, Control, and Treatment of Mpox Virus in 2025: A Comprehensive Review from Infection Mechanisms to Vaccine Development

review Full Text OpenAlex

Genomic epidemiology uncovers the origin of the mpox epidemic in Sierra Leone

preprint Full Text OpenAlex

近5年高被引文献
Monkeypox Virus Infection in Humans across 16 Countries — April–June 2022

article Full Text OpenAlex 2049 FWCI184.04977683

Clinical features and management of human monkeypox: a retrospective observational study in the UK

article Full Text OpenAlex 1236 FWCI110.97118897

SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses

article Full Text OpenAlex 999 FWCI124.30552285

Antibody evasion properties of SARS-CoV-2 Omicron sublineages

article Full Text OpenAlex 843 FWCI105.77861713

Antibody evasion by SARS-CoV-2 Omicron subvariants BA.2.12.1, BA.4 and BA.5

article Full Text OpenAlex 812 FWCI101.0217089

Attenuated fusogenicity and pathogenicity of SARS-CoV-2 Omicron variant

article Full Text OpenAlex 731 FWCI91.88343784

Omicron Variant (B.1.1.529): Infectivity, Vaccine Breakthrough, and Antibody Resistance

article Full Text OpenAlex 698 FWCI85.62434807

SARS-CoV-2 Omicron variant: Antibody evasion and cryo-EM structure of spike protein–ACE2 complex

article Full Text OpenAlex 675 FWCI83.74662114

Clinical presentation and virological assessment of confirmed human monkeypox virus cases in Spain: a prospective observational cohort study

article Full Text OpenAlex 653 FWCI58.55309077

Prevention and Treatment of Monkeypox

article Full Text OpenAlex 628 FWCI56.38779927